Navigation Links
Data supporting three Antisoma programmes presented at AACR

LONDON, and LOS ANGELES, 16 April 2007- Antisoma announces that preclinical data supporting three of its drugs are presented this week at the Annual Meeting of the American Association of Cancer Research (AACR).

AS1404-Avastin-paclitaxel triple combination highly effective Antisoma's scientists have for the first time evaluated a triple combination of the Company's vascular disrupting agent, AS1404, the anti-angiogenic Avastin and the chemotherapy drug paclitaxel. The triple combination had powerful and synergistic (more than additive) anti-tumour effects in a human lung cancer xenograft model. Moreover, addition of Avastin and paclitaxel to AS1404 did not increase toxicity.

These observations build on previous xenograft findings showing a synergistic effect with an AS1404-paclitaxel combination. That effect translated into a substantial survival benefit in a phase II trial in non-small cell lung cancer. Preparations are being made for a pivotal phase III trial combining AS1404 with chemotherapy in lung cancer. The market opportunity in this setting is large, and would be further extended if AS1404 also proved effective when added to an Avastin-chemotherapy combination.

Synergistic effect of AS1404 combined with Erbitux In a second combination study, AS1404 showed synergistic anti-tumour effects with Erbitux in a lung cancer model. These findings, together with the Avastin data, show that AS1404 has potential in combination with newer, targeted therapies as well as longer established treatments such as chemotherapies.

Broad potential of AS1411 alone and in combination New data show that the aptamer drug AS1411 kills cells from a wide variety of cancer cell lines. These include lines representing the four most common cancers: lung, breast, prostate and colorectal; as well as renal, gastric, pancreatic, melanoma, glioblastoma and certain blood cancer lines. Doses lethal to cancer cells
'"/>




Page: 1 2 3 4

Related medicine technology :

1. Antisoma Announces Further Data From ASA404 Ovarian Cancer Trial
2. Antisoma plc (UK) - Second lung cancer trial adds to positive data on AS1404
3. CYT003-QbG10 to treat allergy to be presented at the Congress of the European Academy of Allergology and Clinical Immunology (EAACI), June 9-13, 2007
4. Data to be presented at AAN Meeting -Study results of drug candidate for MS
Post Your Comments:
*Name:
*Comment:
*Email:
TAG: Data supporting three Antisoma programmes presented AACR
(Date:5/27/2015)... 27, 2015 Research and ... the  "North America Portable X Ray Devices Market ...  report to their offering.       (Logo: ... market for Portable X-Ray Devices is ... 2014 to 2020 X-Ray is a ...
(Date:5/27/2015)... 27, 2015 The global vitreoretinal ... market with analysis and forecast of revenue. This market ... is estimated to grow at a CAGR of 8.9 ... the TOC of the global vitreoretinal surgery devices market ... provided. This report also provides a glimpse of the ...
(Date:5/27/2015)... 2015  Marcio Donatelli, a senior marketing associate with the animal health ... volunteer work in a healthcare setting in Bangkok, Thailand ... for people in need with respect and dignity is the guiding star ... -based Elanco employee in a LillyPad blog . Donatelli ... , Colombia , France , ...
Breaking Medicine Technology:North America Portable X Ray Devices Market Report 2015 - Growth, Trends And Forecasts 2014-2019 2Vitreoretinal Surgery Devices Market is Expected to Reach $1,017.8 Million by 2019, at a CAGR of 8.9 % From 2014 to 2019 2Vitreoretinal Surgery Devices Market is Expected to Reach $1,017.8 Million by 2019, at a CAGR of 8.9 % From 2014 to 2019 3Lilly Sends Employees to Serve in Vulnerable Communities around the World 2Lilly Sends Employees to Serve in Vulnerable Communities around the World 3
... Md., May 16, 2011 Science, public health, and ... Drug Administration. Information in this document is designed for credentialed ... of May 16, 2011. (Logo: http://photos.prnewswire.com/prnh/20090824/FDALOGO ... any regulatory or enforcement actions due to legal limitations. ...
... RATON, Fla., May 16, 2011 Breckenridge Pharmaceutical, ... have reached an agreement with Takeda Pharmaceutical Company ... litigation related to Pioglitazone Hydrochloride 15 mg, 30 ... version of Actos®. Under the terms of the ...
Cached Medicine Technology:FDA News & Notes - Week of May 16, 2011 2FDA News & Notes - Week of May 16, 2011 3Breckenridge Pharmaceutical Announces Settlement of Actos® (Pioglitazone Hydrochloride) Patent Litigation 2
(Date:5/27/2015)... As the U.S. Supreme Court considers the ... the Affordable Care Act (ACA), an investigation by the ... RAND Corporation and Express Scripts provides an unprecedented look ... enrollees. , The analysis is published online as ... also appear in the journal’s June issue. , The ...
(Date:5/27/2015)... BBB Code of Business Practices represents sound advertising, selling ... confidence in business. The Code is built on the ... elements of creating and maintaining trust in business. This ... Businesses based in the United States and Canada that ... accredited by BBB. , To be accredited by the ...
(Date:5/27/2015)... May 27, 2015 Hundreds of ... behalf of individuals who allegedly suffered gynecomastia (male ... use of the antipsychotic drug continue to move ... in Pennsylvania’s Philadelphia Court of Common Pleas. According ... its bellwether trial program, as the third trial ...
(Date:5/27/2015)... IL (PRWEB) May 27, 2015 While ... treat hair loss, a new pilot study conducted by ... Restoration Surgery (ISHRS) has found hair follicle grafting can ... cutting-edge research was partially funded by ISHRS, which offers ... relating to hair restoration. , In the past ...
(Date:5/27/2015)... Stamford, CT (PRWEB) May 27, 2015 ... Skin Institute based in Stamford, CT has been selected ... of the first physicians nationwide (and the only physician ... injectable which allows for the removal of submental ... little to no recovery time, no surgery and minimal ...
Breaking Medicine News(10 mins):Health News:Large-Scale Analysis of Medication Data Provides Insights into Who Is Covered by Affordable Care Act 2Health News:Large-Scale Analysis of Medication Data Provides Insights into Who Is Covered by Affordable Care Act 3Health News:Large-Scale Analysis of Medication Data Provides Insights into Who Is Covered by Affordable Care Act 4Health News:Carson Energy Receives A+ Accredited Rating For 19 Consecutive Years 2Health News:Risperdal Lawsuit Attorneys at Bernstein Liebhard LLP Look Forward to Start of Third Gynecomastia Bellwether Trial in Pennsylvania 2Health News:Risperdal Lawsuit Attorneys at Bernstein Liebhard LLP Look Forward to Start of Third Gynecomastia Bellwether Trial in Pennsylvania 3Health News:New Research Finds Hair Grafting a Promising Therapy for Chronic Leg Ulcers - International Society of Hair Restoration Surgery Awards Research Grant 2Health News:New Research Finds Hair Grafting a Promising Therapy for Chronic Leg Ulcers - International Society of Hair Restoration Surgery Awards Research Grant 3Health News:Connecticut Skin Institute First in Connecticut to Offer New Surgery-Free “Double Chin” Fat Reduction Treatment 2Health News:Connecticut Skin Institute First in Connecticut to Offer New Surgery-Free “Double Chin” Fat Reduction Treatment 3
... finds , THURSDAY, June 11 (HealthDay News) -- Mad cow ... somehow goes astray and deprives the healthy brain cells of ... considered a prion disease because it has been found to ... is found on the surface of many cells -- including ...
... ... media age. , ... (Vocus) June 11, 2009 -- From cyberbullying and violent video games to social networking and ... To help parents navigate this new and changing landscape, the Center on Media and ...
... of the crime in cancer are guilty of the initiation and ... disease, a team led by scientists at The University of Texas ... Cancer Cell . "We have a smoking gun" that ... that makes them are abnormally expressed in many types of cancer, ...
... Wii may help treat symptoms of Parkinson,s disease, including ... Parkinson,s disease is a degenerative disease that impairs ... game console, which simulates various sports and activities, could ... found additional benefits as well. "The Wii allows ...
... fifth most common malignancy worldwide and the third leading ... been associated with HCC. However, the relationship between type ... the effects of antidiabetic therapy on HCC risk have ... led by Dr. Valter Donadon from Pordenone Hospital addressed ...
... common cancers in China. Although the association between the ... the relation between smoking, alcohol drinking, family history of ... still remains uncertain. So it is important to investigate ... sporadic colorectal cancer. A research team led by ...
Cached Medicine News:Health News:Protein Branded As Culprit in Mad Cow Disease 2Health News:Center on Media and Child Health Launches "Ask the Mediatrician" 2Health News:Center on Media and Child Health Launches "Ask the Mediatrician" 3Health News:Researchers identify 4 new targets for breast cancer 2Health News:Wii-hab may enhance Parkinson's treatment 2
Instrument for transphenoidal hypophysectomy, bayonet-shaped, dissector, sharp inner edge, left....
Landolt hypophysectomie instrument, spoon, bayonet-shaped, flexible....
Cushing pituitary spoons, malleable copper, silver plated....
... Cougar is an Anterior Spinal Implant system. ... approximating that of cortical bone. The result ... requirements of anterior column support, while optimizing ... sharing design. Incorporates an anatomic design with ...
Medicine Products: